These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30760846)

  • 1. A randomised controlled trial of nasal decongestant to treat obstructive sleep apnoea in people with cervical spinal cord injury.
    Wijesuriya NS; Eckert DJ; Jordan AS; Schembri R; Lewis C; Meaklim H; Booker L; Brown D; Graco M; Berlowitz DJ
    Spinal Cord; 2019 Jul; 57(7):579-585. PubMed ID: 30760846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of nasal decongestion on obstructive sleep apnoea.
    An Y; Li Y; Kang D; Sharama-Adhikari SK; Xu W; Li Y; Han D
    Am J Otolaryngol; 2019; 40(1):52-56. PubMed ID: 30243839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.
    Mason M; Cates CJ; Smith I
    Cochrane Database Syst Rev; 2015 Jul; (7):CD011090. PubMed ID: 26171909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auto-titrating continuous positive airway pressure treatment for obstructive sleep apnoea after acute quadriplegia (COSAQ): study protocol for a randomized controlled trial.
    Berlowitz DJ; Ayas N; Barnes M; Brown DJ; Cistulli PA; Geraghty T; Graham A; Lee BB; Morris M; O'Donoghue F; Rochford PD; Ross J; Singhal B; Spong J; Wadsworth B; Pierce RJ
    Trials; 2013 Jun; 14():181. PubMed ID: 23777510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High nasal resistance is stable over time but poorly perceived in people with tetraplegia and obstructive sleep apnoea.
    Wijesuriya NS; Lewis C; Butler JE; Lee BB; Jordan AS; Berlowitz DJ; Eckert DJ
    Respir Physiol Neurobiol; 2017 Jan; 235():27-33. PubMed ID: 27697626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of treating severe nasal obstruction on the severity of obstructive sleep apnoea.
    McLean HA; Urton AM; Driver HS; Tan AK; Day AG; Munt PW; Fitzpatrick MF
    Eur Respir J; 2005 Mar; 25(3):521-7. PubMed ID: 15738298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of nasal tramazoline with dexamethasone in obstructive sleep apnoea patients.
    Koutsourelakis I; Minaritzoglou A; Zakynthinos G; Vagiakis E; Zakynthinos S
    Eur Respir J; 2013 Oct; 42(4):1055-63. PubMed ID: 23397296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does nasal decongestion improve obstructive sleep apnea?
    Clarenbach CF; Kohler M; Senn O; Thurnheer R; Bloch KE
    J Sleep Res; 2008 Dec; 17(4):444-9. PubMed ID: 18710420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial.
    Lim R; Messineo L; Grunstein RR; Carberry JC; Eckert DJ
    J Physiol; 2021 Sep; 599(17):4183-4195. PubMed ID: 34174090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal Resistance Is Elevated in People with Tetraplegia and Is Reduced by Topical Sympathomimetic Administration.
    Gainche L; Berlowitz DJ; LeGuen M; Ruehland WR; O'Donoghue FJ; Trinder J; Graco M; Schembri R; Eckert DJ; Rochford PD; Jordan AS
    J Clin Sleep Med; 2016 Nov; 12(11):1487-1492. PubMed ID: 27568894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug therapy for obstructive sleep apnoea in adults.
    Smith I; Lasserson TJ; Wright J
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003002. PubMed ID: 16625567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapy for obstructive sleep apnoea in adults.
    Mason M; Welsh EJ; Smith I
    Cochrane Database Syst Rev; 2013 May; (5):CD003002. PubMed ID: 23728641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The feasibility of using auto-titrating continuous positive airway pressure to treat obstructive sleep apnoea after acute tetraplegia.
    Berlowitz DJ; Spong J; Pierce RJ; Ross J; Barnes M; Brown DJ
    Spinal Cord; 2009 Dec; 47(12):868-73. PubMed ID: 19488050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive airway pressure for sleep-disordered breathing in acute quadriplegia: a randomised controlled trial.
    Berlowitz DJ; Schembri R; Graco M; Ross JM; Ayas N; Gordon I; Lee B; Graham A; Cross SV; McClelland M; Kennedy P; Thumbikat P; Bennett C; Townson A; Geraghty TJ; Pieri-Davies S; Singhal R; Marshall K; Short D; Nunn A; Mortimer D; Brown D; Pierce RJ; Cistulli PA;
    Thorax; 2019 Mar; 74(3):282-290. PubMed ID: 30538163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral appliances for obstructive sleep apnoea.
    Lim J; Lasserson TJ; Fleetham J; Wright J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004435. PubMed ID: 15495109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral appliances for obstructive sleep apnoea.
    Lim J; Lasserson TJ; Fleetham J; Wright J
    Cochrane Database Syst Rev; 2003; (4):CD004435. PubMed ID: 14584014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal continuous positive airway pressure with supplemental oxygen in coexistent sleep apnoea-hypopnoea syndrome and severe chronic obstructive pulmonary disease.
    Sampol G; Sagalés MT; Roca A; de la Calzada MD; Bofill JM; Morell F
    Eur Respir J; 1996 Jan; 9(1):111-6. PubMed ID: 8834343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nasal or oral breathing route on upper airway resistance during sleep.
    Fitzpatrick MF; McLean H; Urton AM; Tan A; O'Donnell D; Driver HS
    Eur Respir J; 2003 Nov; 22(5):827-32. PubMed ID: 14621092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.
    Marin JM; Carrizo SJ; Vicente E; Agusti AG
    Lancet; 2005 Mar 19-25; 365(9464):1046-53. PubMed ID: 15781100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zolpidem increases sleep efficiency and the respiratory arousal threshold without changing sleep apnoea severity and pharyngeal muscle activity.
    Messineo L; Eckert DJ; Lim R; Chiang A; Azarbarzin A; Carter SG; Carberry JC
    J Physiol; 2020 Oct; 598(20):4681-4692. PubMed ID: 32864734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.